August 25, 2026 Integration and Breakthroughs:APAMI 2026 Held Successfully in Chengdu, Sichuan, China
August 25, 2026 Molecular Partners Reports H1 2026 Financial Results and Corporate Highlights: DLL3 Radiotherapy MP0712 Successfully Advancing to Higher Dose Level in Phase 1/2a Study